HEMGENIX ®, the first and only FDA-approved gene therapy for adults with hemophilia B, wins for Best Product for Rare/Orphan Diseases "CSL is humbled and honored to receive a Prix Galien award for ...
Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL's three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the ...
ESA has issued an Announcement of Opportunities calling for proposals for innovative technology developments. This is part of the Agency’s Leading-Edge Technology Programme targeted at SMEs. Proposals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback